For Raymond Johnson it was bad enough being diagnosed with cancer when he was just 26 and with no health insurance, but his shock was only aggravated when he was denied Medicaid, because rules say men are not covered for breast cancer.   Johnson, a construction worker from Charleston, S.C., i

North Dakota State University professor Chung S. Park is among the researchers presenting at the Era of Hope scientific conference in Orlando, Fla., Aug. 2-5, hosted by the Department of Defense Breast Cancer Research Program (BCRP). Research by Dr. Park suggests that a pregnant mother's diet that c

The B.C. Supreme Court has certified a class-action lawsuit on behalf of women who developed breast cancer after taking hormone replacement therapy. The lawsuit alleges that the makers of Premarin and Premplus, prescription drugs that treat hot flashes and other symptoms of menopause, failed to inf

A woman's ethnicity as well as her genetic makeup are two of the main risk factors for hereditary breast cancer. Research into understanding and treating hereditary breast cancer were presented at the Era of Hope conference, a scientific meeting hosted by the Department of Defense Breast Cancer Rese

A woman's chance of developing breast cancer depends on a range of factors, including family history, age, time of menopause and whether she has had children. However, a new study has said that older women who are dangerously overweight are at a far higher risk even than those who drink heavily or

Despite equal access to health care as part of the Department of Defense Military Health System, black women were less likely than white women to receive chemotherapy or hormone therapy for regional-stage breast tumors. “With 207,090 new diagnoses and 39,840 deaths estimated for 2010, breast cance

Increasing breast density conferred a progressively greater risk of breast cancer with aggressive characteristics in postmenopausal women, according to a subgroup analysis of a large cohort study.   Women with ≥50% breast density on mammographic study had triple the risk of breast cancer comp

Telomeres, the complex structures that protect the end of chromosomes, of peripheral blood cells are significantly shorter in patients with familial breast cancer than in the general population. Results of the study carried out by the Human Genetics Group of the Spanish National Cancer Research Cent

(Reuters) - A U.S. federal appeals court affirmed the right of Myriad Genetics to patent two genes linked to breast cancer, overturning a lower court ruling that threatened a key element of the biotech business. The U.S. Court of Appeals for the Federal Circuit in a ruling on Friday backed Myriad's

Using human breast cancer cells and the protein that causes fireflies to glow, a Johns Hopkins team has shed light on why some breast cancer cells become resistant to the anticancer effects of the drug tamoxifen. The key is a discovery of two genetic "dimmer switches" that apparently control how a b